Please contact us using a relevant form below. We’ll get back to you as soon as possible.
Your Name *
Your Email *
Your Phone number *
Office for Medicinal Cannabis (OMC)
t: +31 70 340 51 13
t: 1 855 420 7887 (toll free) or 1 855 558 9333
For all media enquiries, you can reach us at firstname.lastname@example.org.
For ordering placebo material or if you are looking for herbal medicinal cannabis as an active pharmaceutical ingredient (API), please contact our sales representatives at email@example.com.
If you are seeking our advice in setting up clinical studies with herbal cannabis or cannabis-based products, please contact our experts at firstname.lastname@example.org.
9640 CA Veendam
t: +31 598 62 37 31
Cannabis & Science - On 18/04 our chairman will speak about why good manufacturing practice (GMP) is important https://t.co/33DguBVDBa- Monday Apr 10 - 11:41am
In Poland we talk about our experience in medicinal cannabis cultivation and our involvement in clinical research. https://t.co/6cG9EoYLYn- Wednesday Feb 1 - 1:16pm
What does our recently achieved GMP status actually mean? We explain at https://t.co/wBaZgX88Zs https://t.co/WiTnDXK0aQ- Tuesday Jan 31 - 8:23am
4 weeks ago
For those located in Argentina, tomorrow there is an interesting conference about medicinal cannabis. Location: La Universidad Nacional de Jujuy, Argentina. More information can be found on the university's website http://www.unju.edu.ar/Agendas.php?id=1391 ... See MoreSee Less
Argentina has given final legislative approval to a bill legalising cannabis oil for medicinal use and permitting the federal government to grow marijuana for research and therapeutic purposes.http://internacional.elpais.com/internacional/2017/03/30/actualidad/1490830376_425239.html ... See MoreSee Less
Argentina aprueba el uso medicinal de la marihuana
La norma garantiza a ciertos pacientes el acceso al aceite de cannabis, pero no el autocultivo
1 month ago
On the 18th and 19th of April the Cannabis and Science conference will be held at the Mendel University of Brno, Czech Republic. Tjalling Erkelens, our chairman of the board, will speak about why good manufacturing practice (GMP) is crucial in medicinal cannabis cultivation. “If the world wants cannabis as a medicine, we have to take the royal road to get there”, he says. Please have a look at the full conference program at our website: https://bedrocan.com/about-us/where-we-speak/ ... See MoreSee Less
2 months ago
This year marks the start of a series of double blind, placebo controlled clinical studies with standardised, pharmaceutical grade medicinal cannabis. We already wrote about a study in Australia (palliative care, January 11th on this timeline). There's one in The Netherlands too...http://bedrocan.com/lumc-starts-clinical-study-on-fibromyalgia-and-cannabis/ ... See MoreSee Less
LUMC starts clinical study on fibromyalgia and cannabis - Bedrocan International
This year marks the start of a worldwide series of double-blind, placebo controlled clinical trials ...
There is a breakthrough for medical cannabis in Sweden. After several years of struggle, Swedish patients will now get cannabis on prescription for the first time. https://www.svd.se/genombrott-for-medicinsk-cannabis-i-sverige ... See MoreSee Less
Läkarnas genombrott: Får skriva ut medicinsk cannabis
Efter flera års kamp, ska nu svenska patienter för första gången få ut cannabis på recept. Lä...
View on Facebook
We're not around right now. But you can send us an email and we'll get back to you, asap.
Start typing and press Enter to search